Related Experiment Video
Updated: Jul 18, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
The challenges of managing and treating Guillain-Barré syndrome during the acute phase
Stephanie B Atkinson1, Rebecca Lamb Carr, Patricia Maybee
1Gastroenterology Associates, Spartanburg, SC, USA.
Abstract:
Guillain-Barré syndrome (GBS) is a randomly acquired inflammatory disease that affects approximately 2 persons in 100,000 annually. There have been no discriminating risk factors identified including age, sex, or race. The syndrome results in the demyelination of peripheral nerves, which leads to progressive motor weakness and paralysis. The critical care nurse should gain from this article an overview of Guillain-Barré syndrome during the acute phase. Included is the pathophysiology of the syndrome, clinical presentation, acute phase nursing assessment and management, and currently available treatment options.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Coronary Syndrome IV: Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management